COVID-19: Prevailing Clinical, Imaging, Healthcare, and Economic Issues of 2022

Free registration for ARRS members

Presented by radiologists across multiple subspecialties, alongside experts in epidemiology, public health, and oncology, COVID-19: Prevailing Clinical, Imaging, Healthcare, and Economic Issues of 2022 will deliver a frontline-focused update on the principal problems still plaguing physicians around the world.

Initially seen as a primarily respiratory illness, as this novel coronavirus disease spread globally, both the clinical and radiologic manifestations of its infection continued to morph; COVID-19 now affects every organ system of the human body. With half of the patients hospitalized for COVID-19 showing persistent lingering symptoms—and up to 30% of symptomatic non-hospitalized patients and even 20% of originally asymptomatic individuals—imaging professionals need to recognize the so-called “long-haul” symptoms of COVID-19, too.

Within months of their widespread availability, the rapidly developed, albeit highly efficacious COVID-19 vaccines began curtailing new cases, extended hospitalizations, and related deaths. However, an enduring strain of vaccine hesitancy has allowed SARS-CoV-2 and its more virulent variants to surge, once again taxing our health care system and economy. Relevant for private practice, academic, and in-training radiologists alike—as well as primary care providers and critical medicine attending and fellows—COVID-19: Prevailing Clinical, Imaging, Healthcare, and Economic Issues of 2022 will also address vaccine hesitancy, post-vaccination complications, boosters for the immunosuppressed, and associated therapeutics.

  • Earn up to 4 CME and 4 live Self-Assessment (SA-CME) credits during and after the presentation through January 27, 2023
  • Learn from accomplished faculty
  • Gain insights into prevailing issues of COVID-19
  • And more!
Registration DeadlineJanuary 28

Members: FREE
In-Training: FREE
Nonmembers: $499

Join ARRS to receive free registration

Course Director

Mark Parker, MD

Course Faculty

Jigna Zatakia, MD

Ali Gholamrezanezhad, MD

Michael Stevens, MD

João Machado Horvat, MD

Mati Hlatshwayo Davis, MD

Ziad El Bakouny, MD

Jason Naidich, MD


View Full Schedule and Faculty

Registration Information

Register today to attend the COVID-19: Prevailing Clinical, Imaging, Healthcare, and Economic Issues of 2022 Virtual Symposium! See table below for rates.

Your membership must be current at the time of registration as well as for the duration of the Symposium in order to receive the member rate promotion. Nonmembers who wish to apply for ARRS membership and receive the member registration promotion must do so no later than January 21, 2022. See below for more information on becoming a member.

Virtual Symposium

The Virtual Symposium provides live broadcasting of symposium sessions online. All sessions will broadcast in Eastern Time Zone. Sessions and credit on demand will also be available to virtual registrants through January 27, 2023.

Virtual Symposium Regular Registration
Through January 28
ARRS In-Training Member  FREE
Nonmember  $499

Virtual Registration Policies

Join to Receive the Member Rate: To join and receive the member rate, submit a membership application online. Once you have received confirmation that your membership has been processed, you may register for the symposium. In order to be eligible to receive the discounted member registration fees, the membership application must be received no later than January 21, 2022.

Join ARRS to receive free registration

Please contact ARRS if you have any questions at 866-940-2777 or 703-729-3353 or Registrations by phone will not be accepted.

Audio/Video Recording Policy: Audio/Video recording including screen capturing or photography of any ARRS educational offering of any type is not allowed. Violations of this policy will be subject to access termination.

Virtual Cancellation Policy: On-demand access and credit claiming for this meeting will be available through January 27, 2023. Should you still need to cancel your registration, written cancellation requests received by January 27, 2022 will be refunded by check after the meeting, minus a 25% cancellation fee. The 25% cancellation fee is nonrefundable. After January 27, 2022, absolutely no refunds will be issued.

ARRS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
ARRS designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™ and 4 American Board of Radiology©, MOC Part II, live Self-Assessment CME (SA-CME) credits. Physicians should claim only the credit commensurate with the extent of their participation in an activity.  
Credit On-Demand Sessions: ARRS designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


COVID-19: Prevailing Clinical, Imaging, Healthcare, and Economic Issues of 2022
Course Director: Mark Parker, MD

All times reflect Eastern Time Zone
Friday, January 28, 2022
Session Topic Faculty
12:00–12:30 pm Current State of COVID Mutations and Variants
Mark Parker, MD
12:30–1:00 pm Long COVID Survivors: Spectrum of Clinical Symptoms and Treatments 
Jigna Zatakia, MD
1:00–1:30 pm Long COVID: Spectrum of Thoracic Imaging Findings
Ali Gholamrezanezhad, MD
1:30–1:45 pm Break

1:45–2:15 pm Status of Vaccines and Therapies for COVID
Michael Stevens, MD
2:15–2:45 pm Post-Vaccination Complications/COVID Vaccination Boosters in the Immunosuppressed
João Machado Horvat, MD
2:45–3:15 pm How to Overcome Vaccine Hesitancy and the Implication of Such
Mati Hlatshwayo Davis, MD
3:15–3:45 pm Impact of the COVID Pandemic on Cancer Screening
Ziad El Bakouny, MD
3:45–4:15 pm Financial Impact of COVID on the US Economy, Healthcare System and Radiology
Jason Naidich, MD
4:15–4:45 pm Question and Answer Session

This schedule is subject to change.

Learning Outcomes

By the end of this course, participants will be able to:

  • Summarize the current state of COVID-19 mutations and variants  
  • Recognize the wide spectrum of clinical symptoms experienced by long COVID survivors, the imaging manifestations of long COVID, and the current approved treatment strategies
  • Discuss the current status of vaccine therapies for COVID, possible post-COVID vaccine complications, how to address vaccine hesitancy, and the role of booster vaccinations in susceptible patient populations
  • Present insights of how the COVID pandemic adversely impacted early detection lung, colorectal, and breast cancer screening programs and their patients
  • Describe the financial toll the COVID pandemic has taken and continues to take on our economy, the healthcare system, and radiology in particular

Target Audience

The target audience for this activity is radiologists, radiologists-in-training, primary health care providers, ER radiologists, and critical care medicine attending and fellows with an interest in image findings of COVID-19 infection.

On-Demand Sessions with Credit

Can’t watch a session live? Don’t worry.
All sessions will be available with credit on demand for all registrants. Simply view the recordings and complete the evaluation form on the credit claiming site to earn your credit. In addition, you can earn Self-Assessment credits by completing the questions for each session.

When can you access On-Demand Sessions?
On-demand sessions will be available through January 27, 2023. The complete recording of the Virtual Symposium will be available within 24 hours of the live session’s completion. Once registrants have received the email that the recorded sessions are available, registrants can begin to view on-demand sessions. Session recordings and credit on demand will be available until January 27, 2023.

Prior to the symposium, all registrants will receive information by email on how to access and view On-Demand Sessions and claim credit.

Disclosure of Commercial Interest

The following faculty members and planners have indicated that they do not have a financial relationship with a commercial organization that may have a direct or indirect interest in the subject matter being presented, or with any commercial organization that has provided funds for the educational activity:

  • Kerry Davis has nothing to disclose. 
  • Ali Gholamrezanezhad has nothing to disclose.
  • João Horvat has nothing to disclose. 
  • John Leyendecker has nothing to disclose. 
  • Jeremiah Long has nothing to disclose.
  • Jason Naidich has nothing to disclose. 
  • Christopher Neumann has nothing to disclose.
  • Mark Parker has nothing to disclose
  • Lubdha Shah has nothing to disclose.
  • Michael Stevens has nothing to disclose. 
  • Jigna Zatakia has nothing to disclose. 

The following individuals have indicated that they have a disclosure of commercial interest:

  • Ziad El Bakouny’s institution receives research support from Genentech/imCORE & Bristol-Myers Squibb. He receives an honorarium as a contributor to UpToDate.